Trial · NCT02383940
Results by group14
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 14 of 14
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in Hemoglobin A1C (A1C) at Week 12 | Placebo | -0.99 | Standard Error 0.149 | percentage of A1C | |
| Change From Baseline in Hemoglobin A1C (A1C) at Week 12 | Sotagliflozin 400 mg | -1.33 | Standard Error 0.143 | percentage of A1C | |
| Change From Baseline in Total Daily Bolus Insulin Dose and Total Daily Basal Insulin Dose at Week 12 | Placebo | Total Daily Bolus Insulin Dose | -2.96 | Standard Error 1.945 | International Units per day (IU/day) |
| Change From Baseline in Total Daily Bolus Insulin Dose and Total Daily Basal Insulin Dose at Week 12 | Sotagliflozin 400 mg | Total Daily Bolus Insulin Dose | -4.89 | Standard Error 1.832 | International Units per day (IU/day) |
| Change From Baseline in Total Daily Bolus Insulin Dose and Total Daily Basal Insulin Dose at Week 12 | Placebo | Total Daily Basal Insulin Dose | 3.26 | Standard Error 1.262 | International Units per day (IU/day) |
| Change From Baseline in Total Daily Bolus Insulin Dose and Total Daily Basal Insulin Dose at Week 12 | Sotagliflozin 400 mg | Total Daily Basal Insulin Dose | 2.03 | Standard Error 1.211 | International Units per day (IU/day) |
| Change From Baseline in 2-hour Postprandial Glucose (PPG) Following a Standardized Mixed Meal at Week 12 | Placebo | 0.2 | Standard Error 12.24 | milligrams per deciliter (mg/dL) | |
| Change From Baseline in 2-hour Postprandial Glucose (PPG) Following a Standardized Mixed Meal at Week 12 | Sotagliflozin 400 mg | -56.4 | Standard Error 11.61 | milligrams per deciliter (mg/dL) | |
Change From Baseline in Glycemic Instability by Hyperglycemia (Continuous Glucose Monitoring [CGM] Area Under the Curve [AUC] >150 mg/dL) and Hypoglycemia (CGM AUC <70 mg/dL) Over a 24-hour Period at Week 12 | Placebo | Glycemic Instability by Hyperglycemia | -5.035 | Standard Error 7.9092 | mg/dL*minutes/1000 |
Change From Baseline in Glycemic Instability by Hyperglycemia (Continuous Glucose Monitoring [CGM] Area Under the Curve [AUC] >150 mg/dL) and Hypoglycemia (CGM AUC <70 mg/dL) Over a 24-hour Period at Week 12 | Sotagliflozin 400 mg | Glycemic Instability by Hyperglycemia | -27.338 | Standard Error 8.0100 | mg/dL*minutes/1000 |
Change From Baseline in Glycemic Instability by Hyperglycemia (Continuous Glucose Monitoring [CGM] Area Under the Curve [AUC] >150 mg/dL) and Hypoglycemia (CGM AUC <70 mg/dL) Over a 24-hour Period at Week 12 | Placebo | Glycemic Instability by Hypoglycemia | 0.221 | Standard Error 0.2508 | mg/dL*minutes/1000 |
Change From Baseline in Glycemic Instability by Hyperglycemia (Continuous Glucose Monitoring [CGM] Area Under the Curve [AUC] >150 mg/dL) and Hypoglycemia (CGM AUC <70 mg/dL) Over a 24-hour Period at Week 12 | Sotagliflozin 400 mg | Glycemic Instability by Hypoglycemia | 0.428 | Standard Error 0.2528 | mg/dL*minutes/1000 |
| Change From Baseline in Number of Hypoglycemic Events/Day (<=70 mg/dL) by Self-Monitored Blood Glucose (SMBG) at Week 12 | Placebo | -0.042 | Standard Error 0.0408 | events/day | |
| Change From Baseline in Number of Hypoglycemic Events/Day (<=70 mg/dL) by Self-Monitored Blood Glucose (SMBG) at Week 12 | Sotagliflozin 400 mg | -0.001 | Standard Error 0.0379 | events/day |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02383940/results